Cargando…
PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer
Background: Although PD-1 blockade has significantly improved the survival of metastatic colorectal cancer with DNA Mismatch Repair-Deficient/Microsatellite Instability-High (MSI-H), the data on neoadjuvant setting is limited. Methods: In this retrospective study, we enrolled eight patients with adv...
Autores principales: | Liu, Ding-Xin, Li, Dan-Dan, He, Wan, Ke, Chuan-Feng, Jiang, Wu, Tang, Jing-Hua, Kong, Ling-Heng, Li, Yuan, Sui, Qiao-Qi, Xiao, Bin-Yi, Li, Wei-Rong, Hong, Zhi-Gang, Xu, Rui-Hua, Pan, Zhi-Zhong, Zhang, Xiao-Shi, Ding, Pei-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984585/ https://www.ncbi.nlm.nih.gov/pubmed/32042474 http://dx.doi.org/10.1080/2162402X.2020.1711650 |
Ejemplares similares
-
The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers
por: Wang, Qiao-Xuan, et al.
Publicado: (2021) -
Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review
por: Mei, Wei-Jian, et al.
Publicado: (2022) -
Evaluation of Concordance Between Deficient Mismatch Repair and Microsatellite Instability Testing and Their Association with Clinicopathological Features in Colorectal Cancer
por: Bai, Huili, et al.
Publicado: (2020) -
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
por: Zhao, Pengfei, et al.
Publicado: (2019) -
Efficacy and safety of preoperative immunotherapy in patients with mismatch repair-deficient or microsatellite instability-high gastrointestinal malignancies
por: Li, Ying-Jie, et al.
Publicado: (2023)